Friday, July 10, 2026
🇺🇸 FDA

Drug profile · INN

diphtheria (d), tetanus (t), pertussis (acellular, component) (pa), hepatitis b (rdna) (hbv), poliomyelitis (inactivated) (ipv) and haemophilus influenzae type-b (hib) conjugate vaccine (adsorbed)

INFANRIX HEXA

diphtheria (d), tetanus (t), pertussis (acellular, component) (pa), hepatitis b (rdna) (hbv), poliomyelitis (inactivated) (ipv) and haemophilus influenzae type-b (hib) conjugate vaccine (adsorbed) (INFANRIX HEXA) is an FDA-listed pharmaceutical active ingredient.

EMA: approved Antiinfectives for systemic use (J07) J07CA09
Patents linked 7
Pipeline programs 67
News articles 0
Drug details — diphtheria (d), tetanus (t), pertussis (acellular, component) (pa), hepatitis b (rdna) (hbv), poliomyelitis (inactivated) (ipv) and haemophilus influenzae type-b (hib) conjugate vaccine (adsorbed)
Class
Antiinfectives for systemic use (J07)
Route
—
Patents
7
Programs
67
Data quality
0.83
← All drugs Related patents Pipeline programs Drug news hub Event calendar

Quick answer

diphtheria (d), tetanus (t), pertussis (acellular, component) (pa), hepatitis b (rdna) (hbv), poliomyelitis (inactivated) (ipv) and haemophilus influenzae type-b (hib) conjugate vaccine (adsorbed) (INFANRIX HEXA) is an FDA-listed pharmaceutical active ingredient.

Key facts

INN diphtheria (d), tetanus (t), pertussis (acellular, component) (pa), hepatitis b (rdna) (hbv), poliomyelitis (inactivated) (ipv) and haemophilus influenzae type-b (hib) conjugate vaccine (adsorbed)
Brand INFANRIX HEXA
Therapeutic class Antiinfectives for systemic use (J07)
ATC code J07CA09

Approval history

Authority Status Date
EMA approved —

Pipeline programs

Search pipeline
  1. DTaP-HB-PRP~T combined vaccine Phase 3 · Sanofi Pasteur MSD · Diphtheria
  2. DTaP-HB-PRP~T vaccine Phase 3 · Sanofi Pasteur MSD · Diphtheria
  3. Experimental vaccine Phase 3 · Sinovac Research and · Poliomyelitis
  4. Hepatitis B adjuvanted vaccine Phase 3 · GSK Glaxo Smith · Hepatitis B
  5. Hexaxim® Phase 3 · Sanofi Pasteur MSD · Diphtheria
  6. Inactivated Poliomyelitis Vaccine (Sabin strains) Phase 3 · Chinese Academy of · Poliomyelitis
  7. Infanrix hexa™ Phase 3 · GSK Glaxo Smith · Poliomyelitis
  8. Investigational sIPV Phase 3 · Sinovac Research and · Poliomyelitis

Related & competitor drugs

Browse all drugs
  1. atazanavir sulfate Antiinfectives for systemic use (J05)
  2. colistimethate sodium Antiinfectives for systemic use (J01)
  3. covid-19 mrna vaccine Antiinfectives for systemic use (J07)
  4. daptomycin Antiinfectives for systemic use (J01)
  5. darunavir Antiinfectives for systemic use (J05)
  6. dengue tetravalent vaccine (live, attenuated) Antiinfectives for systemic use (J07)

Related patents

Browse patents

  1. US 12251561

    Minimally invasive dermal electroporation device

    Expires Mon Mar 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11565107

    Tolerable and minimally invasive skin electroporation device

    Expires Mon Jan 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11291836

    Minimally invasive dermal electroporation device

    Expires Mon Mar 31 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 10668279

    Miniminally invasive dermal electroporation device

    Expires Mon May 28 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 9034313

    Nucleic acid molecules encoding rantes, and compositions comprising and methods of using the same

    Expires Mon May 14 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 7931640

    Method for muscle delivery of drugs, nucleic acids and other compounds

    Expires Mon Apr 21 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 6610044

    Method for genetic immunization

    Expires Mon Aug 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

What is diphtheria (d), tetanus (t), pertussis (acellular, component) (pa), hepatitis b (rdna) (hbv), poliomyelitis (inactivated) (ipv) and haemophilus influenzae type-b (hib) conjugate vaccine (adsorbed)?

diphtheria (d), tetanus (t), pertussis (acellular, component) (pa), hepatitis b (rdna) (hbv), poliomyelitis (inactivated) (ipv) and haemophilus influenzae type-b (hib) conjugate vaccine (adsorbed) (INFANRIX HEXA) is an FDA-listed pharmaceutical active ingredient.

What is the brand name for diphtheria (d), tetanus (t), pertussis (acellular, component) (pa), hepatitis b (rdna) (hbv), poliomyelitis (inactivated) (ipv) and haemophilus influenzae type-b (hib) conjugate vaccine (adsorbed)?

INFANRIX HEXA is a marketed brand name for diphtheria (d), tetanus (t), pertussis (acellular, component) (pa), hepatitis b (rdna) (hbv), poliomyelitis (inactivated) (ipv) and haemophilus influenzae type-b (hib) conjugate vaccine (adsorbed). Check FDA Drugs@FDA for the current US label holder and prescribing information.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.